Stocks XPOF Financial statements
Financial statementsXponential Fitness, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Xponential Fitness, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 129 | 107 | 155 | 243 | 318 | 320 | 315 |
| Cost of revenue | 46.5 | ||||||
| Gross profit | 197 | ||||||
| Selling, general and administrative | 80.5 | 60.9 | 94 | 126 | 169 | 177 | 152 |
| Selling and marketing | 13.6 | 15.7 | 11.9 | 9.72 | |||
| Operating income | -21.1 | 7.79 | -30.8 | 13.3 | 34.9 | -53.6 | 19.8 |
| Interest expense | 16.1 | 21.4 | 24.7 | 13 | 38.7 | 46.3 | 49.2 |
| Interest income | 0.17 | 0.35 | 1.16 | 1.81 | 1.61 | 1.82 | 3.21 |
| Other non-operating income | -15.9 | -21.1 | -19.8 | -11.7 | -40.3 | -45.4 | -72.2 |
| Pre-tax income | -37 | -13.3 | -50.7 | 1.59 | -5.41 | -99 | -52.3 |
| Income tax | 0.16 | 0.37 | 0.78 | 0.49 | 1.03 | -0.34 | 1.32 |
| Net income to minority interests | -32.6 | -0.11 | -2.44 | -31 | -15 | ||
| Net income | -37.1 | -13.6 | -18.8 | 1.22 | -4 | -67.7 | -38.7 |
| EBITDA | -14.7 | 15.4 | -20.6 | 28.6 | 51.8 | -35.9 | 31.9 |
| EPS, basic | -2.85 | -0.88 | 1.08 | -2.27 | -1.47 | ||
| EPS, diluted | -2.85 | -0.88 | -0.52 | -2.27 | -1.47 | ||
| Shares, basic (weighted) | 22.4 | 25.3 | 31.7 | 32 | 34.8 | ||
| Shares, diluted (weighted) | 22.4 | 25.3 | 39.7 | 32 | 34.8 |
Balance sheet
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 11.3 | 21.3 | 37.4 | 37.1 | 32.7 | 45.9 | |
| Receivables | 5.2 | 11.7 | 25.6 | 31.6 | 25.9 | 18.4 | |
| Inventory | 6.16 | 6.93 | 10.9 | 15.6 | 10 | 2.22 | |
| Other current assets | 5.48 | 5.27 | 6.29 | 0.47 | 10.7 | 24.2 | |
| Total current assets | 32.7 | 51.2 | 85.7 | 97 | 84.1 | 94.6 | |
| Property, plant and equipment | 13.7 | 12.8 | 18.5 | 19.5 | 14.7 | 10.9 | |
| Lease right-of-use assets | 0 | 30.1 | 73.5 | 24 | 13.7 | ||
| Goodwill | 140 | 169 | 166 | 171 | 135 | 128 | |
| Intangible assets | 98.1 | 137 | 137 | 120 | 101 | 66.5 | |
| Other non-current assets | 0.61 | 0.55 | 0.8 | 1.44 | 4.36 | 7.21 | |
| Total assets | 323 | 416 | 483 | 530 | 403 | 346 | |
| Accounts payable | 18.3 | 14.9 | 16.2 | 18.6 | 27 | 26.3 | |
| Accrued liabilities | 13.8 | 21 | 12.3 | 19.9 | 31.3 | 51.2 | |
| Deferred revenue | 14.2 | 22.7 | 32 | 34.8 | 25.9 | 19.3 | |
| Short-term debt | 5.8 | 2.96 | 3.04 | 4.76 | 5.4 | 5.25 | |
| Total current liabilities | 54.9 | 65.9 | 72.8 | 102 | 108 | 116 | |
| Long-term debt | 176 | 128 | 133 | 319 | 342 | 501 | |
| Lease liabilities | 0 | 30.6 | 72 | 23.9 | 14.2 | ||
| Other non-current liabilities | 4.41 | 4.68 | 8.63 | 4.97 | 0.25 | 6.99 | |
| Total liabilities | 318 | 349 | 383 | 624 | 597 | 718 | |
| Total debt | 182 | 133 | 138 | 329 | 352 | 525 | |
| Paid-in capital | 0 | 505 | 521 | 504 | 490 | ||
| Retained earnings | -107 | -644 | -642 | -634 | -702 | -741 | |
| Treasury stock | 0 | -1.7 | -1.7 | -1.7 | -1.7 | ||
| Shareholders' equity | 26.7 | 4.75 | -654 | -155 | -130 | -217 | -269 |
| Minority interests | 444 | -53.3 | -79.5 | -94.2 | -103 | ||
| Total equity | 26.7 | 4.75 | -211 | -212 | -210 | -311 | -372 |
| Total liabilities and equity | 323 | 416 | 483 | 530 | 403 | 346 |
Cash flow statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | -37.1 | -13.6 | -51.4 | 1.1 | -6.44 | -98.7 | -53.7 |
| Depreciation and amortization | 6.39 | 7.65 | 10.2 | 15.3 | 16.9 | 17.7 | 12 |
| Stock-based compensation | 2.06 | 1.75 | 9.7 | 29 | 18 | 15.5 | 12.9 |
| Deferred income tax | -0.04 | 0.04 | -1.66 | 0.37 | |||
| Change in receivables | -6.57 | 2.98 | -6.61 | -12.2 | -7.35 | -3.92 | 4.52 |
| Change in inventory | -0.3 | -1.39 | -0.77 | -4.37 | -3.96 | 5.57 | 7.79 |
| Change in payables | 6.53 | 1.71 | -3.01 | ||||
| Cash from operations | 1.55 | -0.73 | 14.5 | 52.1 | 32.7 | 11.7 | 28.3 |
| Capital expenditures | -7.23 | -1.88 | -3.64 | -8.96 | -7.43 | -4.71 | -3.58 |
| Acquisitions | -0.75 | 0 | -44.3 | 0 | -2.57 | -8.5 | 0 |
| Cash from investing | -9.78 | -4.6 | -50.6 | -14.6 | -11.7 | -14.1 | 1.53 |
| Debt issued | 12 | 189 | 256 | 7.43 | 189 | 63 | 516 |
| Debt repaid | -1.6 | -149 | -311 | -2.98 | -4.2 | -43.9 | -392 |
| Stock issued | 0 | 122 | 0 | 0 | |||
| Share buybacks | 0 | 0 | -50.4 | 0 | 0 | ||
| Cash from financing | 6.36 | 7.29 | 46.2 | -21.4 | -21.3 | -1.88 | -16.7 |
| Net change in cash | -1.87 | 1.96 | 10 | 16.1 | -0.28 | -4.36 | 13.1 |
| Free cash flow | -5.68 | -2.61 | 10.8 | 43.1 | 25.3 | 6.96 | 24.7 |
| Interest paid | 12.9 | 17 | 16.1 | 11.6 | 34.8 | 41.3 | 37.5 |
| Income taxes paid | 0.17 | 0.23 | 1.4 | 2.79 | 1.57 | 0.56 | 0.21 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Operating margin | 6.2% | Operating income / revenue. |
| EBITDA margin | 9.7% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -19.9% | Pre-tax income / revenue. |
| Net margin | -14.8% | Net income / revenue. |
| FCF margin | -2.8% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | -2.0% | Cash from operations / revenue. |
| Return on assets (ROA) | -13.7% | Net income / average total assets. |
| Return on invested capital (ROIC) | 8.0% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 50.1% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 3.7% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.8% | Capital expenditures / revenue. |
| D&A / revenue | 3.5% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -1.7% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 9.0% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 24.2% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income CAGR, 3y | 14.2% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 20.6% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA CAGR, 3y | 3.6% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 15.6% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 142.5% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -18.4% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 255.2% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -16.9% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | -14.3% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -10.5% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 1.4% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 8.8% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 11.2% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 0.75x | Current assets / current liabilities. |
| Quick ratio | 0.46x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.27x | (Cash + short-term investments) / current liabilities. |
| Debt / assets | 168.6% | Total debt / total assets. |
| Liabilities / assets | 221.4% | Total liabilities / total assets. |
| Net debt | $497.4M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 17.8x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 0.33x | Operating income / interest expense. |
| Working capital | -$23.6M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 62.3% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$514.4M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.93x | Revenue / average total assets. |
| Fixed asset turnover | 30.6x | Revenue / average property, plant and equipment. |
| Receivables turnover | 16.6x | Revenue / average receivables. |
| Days sales outstanding | 22 days | 365 x average receivables / revenue. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$1.01 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $6.86 | Revenue / diluted weighted shares. |
| FCF per share | -$0.19 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | -$0.14 | Cash from operations / diluted weighted shares. |
| Book value per share | -$7.65 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$12.24 | Tangible book value / shares outstanding. |
| Cash per share | $0.59 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $193.4M | Share price x shares outstanding. |
| Enterprise value | $690.7M | Market cap + total debt - cash - short-term investments. |
| P/S | 0.67x | Market cap / revenue. |
| EV/Sales | 2.39x | Enterprise value / revenue. |
| EV/EBIT | 38.6x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 24.7x | Enterprise value / EBITDA, when both are positive. |
| FCF yield | -4.2% | Free cash flow / market cap. |
| Earnings yield | -22.0% | Net income / market cap (the inverse of P/E). |
What was Xponential Fitness, Inc.'s revenue in fiscal 2025?
Xponential Fitness, Inc. reported revenue of $314.9M for fiscal 2025, 1.7% lower than the year before.
Was Xponential Fitness, Inc. profitable in fiscal 2025?
No. It reported a net loss of $38.7M.
How much free cash flow did Xponential Fitness, Inc. generate in fiscal 2025?
Cash from operations of $28.3M minus capital expenditures of $3.6M left free cash flow of $24.7M.